Medindia

X

GlySure Clears European Regulatory Approval For Novel Glucose Monitoring System

by Julia Samuel on  July 11, 2015 at 11:04 AM Medical Gadgets   - G J E 4
The European regulatory approved GlySure Limited's Continuous Intravascular Glucose Monitoring System (CIGMS). The product will initially be rolled out to leading critical care facilities in the UK, Germany, and the Benelux countries.
GlySure Clears European Regulatory Approval For Novel Glucose Monitoring System
GlySure Clears European Regulatory Approval For Novel Glucose Monitoring System
Advertisement

It is intended for close monitoring of glucose levels in ICU patients. The GlySure CIGMS consists of a disposable central venous catheter, a fiber optic sensor, a monitor that displays the latest glucose reading and a chart covering the last few hours. There's also an accompanying calibration module.

Advertisement
Before the system is used, a calibration module is used to prepare the sensor. It's sterile and comes pre-connected to the fully automated sensor.

Once ready, the catheter and sensor is inserted into the patient, the system is activated and the sensor begins taking readings every fifteen seconds, displaying them on the screen.

The company is now working on finalizing a clinical trial that will be used to demonstrate the system's safety and efficacy to the FDA in order to seek approval in the US.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All